BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38406993)

  • 1. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
    Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA
    Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative solution equilibrium studies of antitumor ruthenium(η
    Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
    Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
    Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA
    Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules.
    Pivarcsik T; Dömötör O; Mészáros JP; May NV; Spengler G; Csuvik O; Szatmári I; Enyedy ÉA
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution equilibrium, structural and cytotoxicity studies on Ru(η
    Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
    J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
    Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA
    J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.
    Beckford F; Dourth D; Shaloski M; Didion J; Thessing J; Woods J; Crowell V; Gerasimchuk N; Gonzalez-Sarrías A; Seeram NP
    J Inorg Biochem; 2011 Aug; 105(8):1019-29. PubMed ID: 21666776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding mechanisms of half-sandwich Rh(III) and Ru(II) arene complexes on human serum albumin: a comparative study.
    Dömötör O; Enyedy ÉA
    J Biol Inorg Chem; 2019 Aug; 24(5):703-719. PubMed ID: 31300922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
    Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
    J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
    Enyedy EA; Sija E; Jakusch T; Hartinger CG; Kandioller W; Keppler BK; Kiss T
    J Inorg Biochem; 2013 Oct; 127():161-8. PubMed ID: 23721887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 8-hydroxyquinoline-proline hybrid with multidrug resistance reversal activity and the solution chemistry of its half-sandwich organometallic Ru and Rh complexes.
    Mészáros JP; Poljarević JM; Szatmári I; Csuvik O; Fülöp F; Szoboszlai N; Spengler G; Enyedy ÉA
    Dalton Trans; 2020 Jun; 49(23):7977-7992. PubMed ID: 32500882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative solution and structural studies of half-sandwich rhodium and ruthenium complexes bearing curcumin and acetylacetone.
    Mészáros JP; Poljarevic JM; Gál GT; May NV; Spengler G; Enyedy ÉA
    J Inorg Biochem; 2019 Jun; 195():91-100. PubMed ID: 30928657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ru(II)-
    Dorairaj DP; Haribabu J; Dharmasivam M; Malekshah RE; Mohamed Subarkhan MK; Echeverria C; Karvembu R
    Inorg Chem; 2023 Jul; 62(30):11761-11774. PubMed ID: 37459067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
    Bíró L; Farkas E; Buglyó P
    Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
    Bhattacharyya S; Purkait K; Mukherjee A
    Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.